Intermittent fasting during chemo for lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests whether intermittent fasting is safe and doable for people with lymphoma who are getting standard chemotherapy (R-CHOP or ABVD). It aims to see if adding fasting periods can help reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diffuse large B-cell lymphoma or Hodgkin lymphoma
- You are getting chemotherapy with R-CHOP or ABVD
- You are 18 to 80 years old
- You are able to manage daily activities (ECOG score 0-2)
- Your body mass index (BMI) is 18.5 or higher
- You do not have diabetes or other conditions that make fasting complicated
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether time-restricted eating (eating only during certain hours of the day) can help people with CLL or SLL (types of blood cancer) and also compares to healthy volunteers. It aims to see if this eating pattern improves health and well-being without needing other treatments.
This study tests whether a personalized exercise program during chemotherapy can help people with lymphoma feel stronger and have fewer side effects. You would take part in supervised exercise sessions twice a week for 20 weeks.
This study looks at whether taking short, frequent breaks from sitting can help people with lymphoma who are starting chemotherapy feel better and have fewer side effects. If you join, you'll get a wearable activity tracker and text reminders to stand up and move gently throughout your day.
This pilot study tests whether alternating periods of lower calorie intake, along with a plant-based diet, is safe and feasible for people receiving chemotherapy. If it helps, it could support better comfort and treatment tolerance during cancer therapy.
This trial tests whether alternating between a fasting day and a normal eating day can help people recovering from gynecologic cancer surgery while they receive chemotherapy. It aims to see if this eating pattern is safe and helpful during treatment.
This study tests whether periods of fasting (eating very little for set times) combined with immunotherapy drugs might help treat advanced cancers like lung, stomach, liver, or melanoma. The goal is to see if fasting helps the immune-boosting drugs work better.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.